Tag: nasdaq:rytm

August 11, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Paratek Up 41 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
August 7, 2019

Rhythm Pharma Rises on Positive Obesity Trial Results

The company says its lead drug candidate achieved its goals in pivotal Phase 3 trials for rare obesity disorders.
August 7, 2019

Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials

Rhythm Pharmaceuticals (NASDAQ:RYTM) has announced positive topline results from two Phase 3 clinical trials testing setmelanotide in pro-opiomelanocortin (POMC) and...
September 28, 2018

Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity

Rhythm Pharmaceuticals (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic...
July 23, 2018

Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity

Rhythm Pharmaceuticals (NASDAQ:RYTM) has announced that the European Agency (EMA) has granted PRIority MEdicines (PRIME) designation for the company’s melanocortin-4...